Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Neovoca Ltd

Neovoca Ltd is a consultancy founded on the belief that the patient is the first customer, and that the goals of industry, healthcare professionals and society, all meet with the aim of improved patient care. To consistently achieve this requires a legitimate and valuable dialogue between the healthcare industry and the consumer. Our Mission, is to help build those conversations by working across the public and private sectors, and our services are centred on helping the pharmaceutical industry achieve a stronger and considered conversation with those consumers who should be benefiting from years of painstaking and rigorous research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

- PMLiVE

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Advertising, Branding, Creative and design, Digital communications, Management consultancies, Marketing consultancies, Media planning and buying, Medical communications, Medical education, Patient support and adherence, Public relations

- PMLiVE

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

Branding, Creative and design, Management consultancies, Market access, Market research, Media planning and buying, Medical communications, Medical education, Public relations

OPEN Health

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Medical education, Patient support and adherence, Public relations, Training

Sciterion Logo

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

Company Details

Neovoca Ltd
The Counting House, Tring, HP23 5TE, United Kingdom
07786 126686
Contact Neovoca Ltd
Website

 Latest Content from PMHub 

Research Partnership launches new patient Living with Ulcerative Colitis (UC) US report

White Papers and Resources | July 5, 2017 | Inizio

Living with Ulcerative Colitis (UC) is a study conducted amongst 100 adult UC patients in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase...

Research Partnership is celebrating 20 years in business

White Papers and Resources | July 5, 2017 | Inizio

Watch our short video to see how we have grown. Please note the video comes with some fun, themed music. https://www.researchpartnership.com/news/2017/06/research-partnership-is-celebrating-20-years-in-bus...

Therapy Watch expands oncology and IBD portfolios

White Papers and Resources | July 5, 2017 | Inizio

This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in...

Lucid Partners grows its medical writing team

Press Releases | June 30, 2017 | Lucid Group Communications Limited

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

PEGASUS SHOWREEL 2017

Videos and Podcasts | June 26, 2017 | Inizio

The new pharma marketing playbook

White Papers and Resources | June 23, 2017 | An agency called Owen

Do you know about the 5 key areas that must be in your pharma marketing playbook?

Pharma needs to evolve from customer-centricity to stakeholder-centricity

White Papers and Resources | June 23, 2017 | An agency called Owen

Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders.

How to plan, execute and refine an excellent congress experience

White Papers and Resources | June 22, 2017 | Blue Latitude Health

Medical congresses are one of the most important and intensive marketing activities a company can undertake. Here, Account Director Dolan Desai and Senior Creative Copywriter Dale Choate give you the...

How can pharma help the NHS capitalise on its data?

White Papers and Resources | June 21, 2017 | Wilmington Healthcare

Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services

21st Century Cures Act: a commercial perspective on how the new FDA regulation could revolutionise use of RWE and analytics in healthcare

White Papers and Resources | June 20, 2017 | Blue Latitude Health

The 21st Century Cures Act has transformed the US drug development landscape. David Cooney explores the implications of the Act for pharmaceutical companies and reveals how it can be leveraged.